baber/WOPTO huggingface dataset:
Patent NZ-322562-A (NZ)
Title: Door security arrangement comprising a sliding elongate member the length of the edge of the door
Inventor: HAMMERSLEY DAVID GEORGE
IPC: E05B53/00
Filed: 1996-11-22
Abstract: PCT No. PCT/GB96/02887 Sec. 371 Date May 20, 1998 Sec. 102(e) Date May 20, 1998 PCT Filed Nov. 22, 1996 PCT Pub. No. WO97/20124 PCT Pub. Date Jun. 5, 1997A door security arrangement with the frame member which is mountable in a wall alongside the opening edge of a door and has an elongate member slideably mounted therein, the member being substantially the same length of the door edge and being movable from a retracted position in which it lies within the frame member and permits the door to swing past it to an extended position in which it lies alongside and substantially against the inner face of the door and the arrangement including releasable means, located within the frame member which hold the elongate member in its retracted and extended positions and are operable by the normal door locking mechanism.
Patent NZ-323855-A (NZ)
Title: Method and compositions for the synthesis of dioxolane nucleosides particularly the beta-configuration of the 1,3-dioxolane sugar rings
Inventor: MANSOUR TAREK
IPC: C07H/
Filed: 1996-12-13
Abstract: The present invention relates to methods and compositions for preparing biologically important nucleoside analogues containing 1,3-dioxolane sugar rings. In particular, this invention relates to the stereoselective synthesis of the beta (cis) isomer by glycosylating the base with an intermediate of formula (II) below a temperature of about -10 C, wherein R1 and L are as defined herein.
Patent NZ-325627-A (NZ)
Title: An adenoviral vector comprising a deletion in the E4 region and its use
Inventor: KOVESDI IMRE
IPC: A61K39/00
Filed: 1996-12-12
Abstract: he present invention provides multiply replication deficient adenoviral vectors having a spacer in at least one replication deficient adenoviral region, as well as complementing cell lines therefor. The adenoviral vector is deficient in at least two regions required for viral production such as the E regions.  Also provided are means of constructing the multiply replication deficient adenoviral vectors and methods of use thereof, e.g., in gene therapy.
Patent NZ-335091-A (NZ)
Title: Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivatives as vasodilators
Inventor: FURSTNER CHANTAL
IPC: A61P25/00
Filed: 1997-10-01
Abstract: The use of condensed (hetaryl-substituted) 1-benzal-3-pyrazol derivates of general formula (I) as vasodilators; wherein R1 is hydrogen, hydroxyl, alkyl or alkoxy, R2 is a radical of formula (II); wherein R5 is hydrogen, halogen, alkyl, alkoxy, carbonyl or a radical of formula -CH2-OR6, in which R6 is hydrogen or alkyl, R3 and R4 together for a radical of formula (III), wherein R7 is hydrogen, halogen, hydroxyl, alkyl of alkoxy.
Patent NZ-502277-A (NZ)
Title: Swollenin protein, encoding DNA sequences and use in detergents, fodder and paper production
Inventor: SWANSON BARBARA A
IPC: C12N1/21
Filed: 1998-07-09
Abstract: A partially or wholly isolated swollenin protein derived from a microbial source is described. Swollenin is described as a protein or polypeptide or domain of a protein or polypeptide of microbial, i.e. fungal or bacterial, origin which has the ability to facilitate weakening of filter paper and the swelling of cotton fibers without having cellulolytic activity, i.e. catalytic activity involving the breakage of individual cellulose strands into smaller monomer (glucose) or oligomers (polysaccharides). Also described are methods providing a DNA sequence corresponding to a microbial swollenin which can be used in an industrial production of swollenin protein. The protein is useful in methods whereupon alteration of cellulosic substrates, such as pulp and paper, cellulose based textile fibers, animal feed and corn wet milling or dry milling polysaccharide waste products or other cellulosic biomass.
Patent NZ-504336-A (NZ)
Title: Tetrahydrofuran substituted adenosine A1 receptor agonists, pharmaceuticals thereof, and their use as medicaments
Inventor: ELDRED COLIN DAVID
IPC: A61P43/00
Filed: 1998-11-06
Abstract: A compound of formula (I), wherein: R2 is C1-3alkyl, halogen or hydrogen. R3 is C1-6 Alkyl. R1 is a group selected from: i) Optionally substituted -(alk)n-(C3-7)cycloalkyl, including bridged cycloalkyl wherein (alk) represents C1-3 alkylene and n is 0 or 1. ii) Optionally substituted aliphatic heterocyclic of 4 to 6 ring members containing at least one heteroatom selected from O, N or S. iii) Optionally substituted alkyl, the alkyl group optionally containing one of more O, S(=O)n (where n is 0, 1 or 2) or N groups substituted within the alkyl chain. iv) A fused bicyclic ring system (II), wherein B is a 5 or 6 membered heterocyclic aromatic ring containing 1 or more O, N or S atoms, wherein the bicyclic ring system is attached to the nitrogen atom of formula (I) via a ring atom or ring A and wherein ring B is optionally substituted by -CO2(C1-3alkyl). v) Optionally substituted phenyl. With the proviso that, when R3 is C1-6alkyl and R2 is C1-3alkyl, R1 cannot represent phenyl substituted by one or more of halogen, C1-3alkyl, trifluoromethyl, nitro, cyano, -CO2Rc, -CONRcRd, -CORc, -SORc, -SO2Rc, -SO3H, -SO2NRcRd, -ORc, -NHSO2Rc, -NHCORc or -NRcRd. Also described is a pharmaceutical composition comprising a compound of formula (I) together with a pharmaceutical carrier and/or excipient. The compounds of formula (I) are useful for the treatment of a patient suffering from or susceptible to ischemic heart disease, peripheral vascular disease or stroke, or which patient is suffering pain, a CNS disorder or sleep apnoea. The compounds of formula (I) are useful for the treatment of a patient suffering from a condition where there is advantage in decreasing plasma free fatty acid concentration, or reducing heart rate.
Patent NZ-504369-A (NZ)
Title: Spiral wound, externally mounted parallel heat exchanger tubes for water heater using heat pump
Inventor: ISLAM RAFIQUL
IPC: F25B30/02
Filed: 1998-11-05
Abstract: A water heater comprises a water tank and a heat pump system (20). The heat exchanger (26) includes an inlet manifold (27) connected to the compressor (22), an outlet manifold (28) connected to the evaporator (25) and a plurality of heat exchange tubes (29, 30) connected in parallel between the inlet and outlet manifolds (27, 28).  The heat exchange tubes (29, 30) are wound helically around the water tank and secured to the tank wall (32) in a heat conductive relation with the tank.  Heat from condensation of the refrigerant liquid circulating through the heat pump system (20) is transferred to water contained in the tank.
Patent NZ-515669-A (NZ)
Title: Beta 2 adrenoceptor agonists
Inventor: BEATTIE DAVID
IPC: A61P11/02
Filed: 2000-06-02
Abstract: Compounds of formula (I) are described, wherein Ar is a group of formula (II), in which Y is C or N, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of a condition that is prevented or alleviated by activation of the Beta2-adrenoreceptor.
Patent NZ-516348-A (NZ)
Title: Substituted benzimidazole
Inventor: RITZELER OLAF
IPC: C07D401/04
Filed: 2000-06-09
Abstract: A benzimidazole derivative or a stereoisomer or a physiologically tolerable salt thereof has the formula I wherein one of the substituents R1, R2, R3 or R4 is -D-N(R8)-C(H)(R9)-Z  and the other substituents R1, R1, R2, R3 or R4 are independently hydrogen, halogen, alkyl, -CN, -NO2, -O-alkylaryl, -O-alkyl, -OR11, -N(R11)2, -S(O)xR11 or -CF3 or optionally substituted heteroaryl having 5 to 14 ring members or heterocycle having 5 to 12 ring members; Z is optionally substituted aryl, heteroaryl having 5 to 14 ring members, a heterocycle having 5 to 12 ring members, alkyl or -C(O)R10; R10, R11 and x are as defined in the specification; R8 is hydrogen or alkyl and R9 is a radical derived from an amino acid (either naturally occurring or not naturally occurring), optionally substituted aryl, heteroaryl having 5 to 14 ring members or alkyl or R8 and R9 together with the nitrogen and carbon to which they are each bonded, form a optionally substituted heterocyclic ring of formula IIa or  R9 and Z together with the carbons to which they each are bonded form an optionally substituted heterocyclic ring of formula IIc; D is -C(O)-, -S(O)-, or -S(O)2-; A is nitrogen or -CH2-; B and X are independently oxygen, sulphur, nitrogen, or -CH2-; Y is absent or is oxygen, sulphur, nitrogen, -CH2- or X and Y together form phenyl, 1,2-diazine, 1,3-diazine, or a 1,4-diazine radical; where the ring system formed by N, A, X, Y, B, and the carbon contains no more than one oxygen, X is not oxygen, sulphur, or nitrogen if A is a nitrogen atom; contains no more than one sulphur; contains 1, 2, 3, or 4 nitrogens; and where oxygen and sulphur do not occur at the same time; T and W are independently oxygen, sulphur, nitrogen, or -CH2-; V is absent or is oxygen, sulphur, nitrogen, or -CH2- or T and V together form a phenyl, 1,2-diazine, 1,3-diazine, or a 1,4-diazine radical or V and W together form a phenyl, 1,2-diazine, 1,3-diazine, or a 1,4-diazine radical; where the ring system formed by N, T, V, W, and the two carbons contains no more than one oxygen, no more than one sulphur, and 1, 2, 3, or 4 nitrogens; where oxygen and sulphur do not occur at the same time; R5 is hydrogen, -OH or  =O; and R6 is optionally substituted aryl or heteroaryl having 5 to 14 ring members. The compounds are useful for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, atherosclerosis and carcinomatous disorders.
Patent NZ-516607-A (NZ)
Title: System and method for extracting water in a dry cleaning process involving a siloxane solvent
Inventor: BERNDT WOLF-DIETER R
IPC: D06F43/08
Filed: 2000-07-13
Abstract: A system and method are provided for separating water from solvent during dry cleaning. Included is an inlet (52) capable of receiving a mixture of dry cleaning fluid and water from a basket of a dry cleaning apparatus. The dry cleaning fluid includes a siloxane composition. Also provided is a flow controller (60) for urging flow of the mixture received from the outlet. Coupled to the flow controller (60) is a coalescent media (64) that receives the mixture urged by the flow controller (60). A chamber (68) is coupled to the coalescent media (64) for receiving the mixture from the coalescent media (64) to separate the water and the dry cleaning fluid. Also coupled to the chamber (68) is an outlet (69) to remove the dry cleaning fluid from the chamber (68) in the absence of water.
Patent NZ-523902-A (NZ)
Title: Paroxetine compositions and processes for making the same
Inventor: VAN DALEN FRANS
IPC: A61K9/50
Filed: 2001-08-28
Abstract: A solid paroxetine composition having a pH of 6.5 or less comprises paroxetine salt and an excipient.
Patent NZ-524079-A (NZ)
Title: Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use
Inventor: PLATZEK JOHANNES
IPC: C07D257/02
Filed: 2001-07-23
Abstract: Perfluoroalkyl-containing complexes with sugar radicals of formula (I), process for their production and their uses are disclosed, wherein: R is a monosaccharide or oligosaccharide radical that is bonded via the 1-OH position or 1-SH position; Rf is perfluorinated, straight chain or branched carbon chain of formula -CnF2nE, wherein E is a terminal fluorine, chlorine, bromine, iodine or hydrogen, and n is 4 to 30; G is as defined in the specification K is a metal complex as defined in the specification; and Y and Z are linker groups as defined in the specification. These perfluoroalkyl-containing complexes with sugar radicals of formula (I) are suitable for use in intravenous lymphography, in tumor diagnosis and for infarct and necrosis imaging.
Patent NZ-525950-A (NZ)
Title: Benzothiophene derivative compounds, process of preparation and use thereof as serotonin reuptake inhibitors with affinity to the 5-HT1A receptor to treat neurological disorders such as psychosis, depression, anxiety and panic attacks
Inventor: DEL CASTILLO NIETO JUAN CARLOS
IPC: C07D333/56
Filed: 2001-11-19
Abstract: The compound of formula (I) is defined wherein: n is 1, 2 or 3 Z is C=O or -CHOH R1 is H, alkyl C1-C6, halogen, -OR2, nitro, cyano, -NR3R4, -COR2, -CO2R2, -O-COR2, SO2NR3R4, -SO2R2, -SR2 or -CONR3R4 R2 is H, alkyl C1-C6 or phenyl; R3 and R4 are independent of each other and stand for H, alkyl C1-C6 or phenyl, or else R3 together with R4 form a morpholine, thiomorpholine or piperazine ring; Ar is an optionally substituted bicyclic system formed by a benzocondensed heterocyclic ring which has 5, 6 or 7 ring atoms, saturated or unsaturated and containing 1, 2 or 3 hetero-atoms selected from N, O and S. Also described is a process for preparing the compound of general formula (I). The compounds can be used in pharmaceutical compositions for use as serotonin reuptake inhibitors and antagonist or agonist of the 5-HT1A receptor and are useful in the treatment of neurological disorders such as depression, psychosis, anxiety, panic attacks, obsessive-compulsive disorders and nutrition disorders.
Patent NZ-528859-A (NZ)
Title: Device for continuous drying of a pulp sheet
Inventor: HAIDER FRANZ
IPC: D21F5/18
Filed: 2003-10-13
Abstract: Device for continuous drying of a pulp sheet, particularly a tissue web, with a drying drum and an air circulating system, whereby the drying drum comprises a shell with a perforated cylinder that is supported on radial bearing rings, whereby longitudinal ribs are provided in axial direction and the longitudinal ribs at the edges of the cylinder being welded to the outermost radial bearing ring only, where the outermost radial bearing ring is not connected to the cylinder shell.
Patent NZ-530156-A (NZ)
Title: Peptide-based compounds for targeting integrin receptors for use as diagnostic imaging agents
Inventor: CUTHBERTSON ALAN
IPC: A61K47/65
Filed: 2002-07-08
Abstract: Disclosed herein are peptide-based compounds having the structure as defined in specification, for use as diagnostic imaging agents or as therapeutic agents wherein the agents comprise targeting vectors which bind to integrin receptors.
Patent NZ-532279-A (NZ)
Title: Combination of a PDE inhibitor and a leukotriene receptor antagonist
Inventor: WEIMAR CHRISTIAN
IPC: A61K31/4409
Filed: 2002-09-17
Abstract: Disclosed are pharmaceutical combinations comprising the PDE4 inhibitor Roflumilast, and a leukotriene receptor antagonist selected from Atreleuton, Acitazanolast, Zileuton, Zafirlukast, Pranlukast, and Montelukast. The combinations are used for the manufacture of medicaments for treating respiratory tract disorders, such as asthma
Patent NZ-532969-A (NZ)
Title: Water tank
Inventor: WALLACE NEIL
Filed: 2004-05-14
Abstract: A water storage tank (10) having a base, first and second containment sheets extending upwardly from the base and opposite sides extending upwardly from the base and interconnecting the first and second containment sheets. At least one of the containment sheets is formed from metal and profiled to incorporate a plurality of stiffening formations (19) extending across the sheet to resist outward bowing of that containment sheet.
Patent NZ-533053-A (NZ)
Title: Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2A receptor agonist
Inventor: SILK TERENCE VERNON
IPC: A61K47/48
Filed: 2002-11-27
Abstract: A crystalline form of 6-[(2,2-diphenylethyl)amino]-9-(N-ethyl-beta-D-ribofuranosyluronamide)-N-(2-{N'-[1-(2-pyridyl)-4-piperidyl]ureido}ethyl)-9H-purine-2-carboxamide; a process for its preparation; and compositions containing the crystalline form of the said ribofuranosyluronamide derivative compound and the pharmaceutical uses of such a crystalline form are disclosed.
Patent NZ-533177-A (NZ)
Title: Floor structure with steel beams being separated by spacers that support upper and/or lower flanges of beams
Inventor: TOKUNO MITSUHIRO
IPC: E04B5/10
Filed: 2004-05-27
Abstract: The floor structure consists of beams 4 in parallel configuration that are separated by spacers 6 that support upper and/or lower flanges 2, 3 of the beams 4. A variety of embodiments are disclosed.
Patent NZ-533548-A (NZ)
Title: Method and apparatus for treatment of a rotor blade on a windmill
Inventor: TEICHERT PAUL
IPC: F03D1/00
Filed: 2002-12-04
Abstract: Method and apparatus for treatment of a surface of a rotor blade of a windmill, whereby a rotor blade is positioned in an immobile position; an apparatus is mounted onto the rotor blade, the apparatus comprising means for surface treatment of the rotor blade; the apparatus is placed in such a manner that it can be moved in relation to the surface of the rotor blade; the apparatus is moved lengthwise along the rotor blade while engaging the rotor blade to directionally guide movement of the apparatus along the rotor blade, and whereby the apparatus is moved in a manner that accords with a treatment form that is carried out on the rotor blade.
Patent NZ-537905-A (NZ)
Title: An upright surface treating appliance such as a vacuum cleaner mounted on a roller or ball support assembly
Inventor: COURTNEY STEPHEN BENJAMIN
IPC: A47L5/28
Filed: 2003-07-18
Abstract: A surface treating appliance 200, such as a vacuum cleaner, includes a main body 210 with a handle 213, a surface treating head 230 and a support assembly 220. The support assembly is mounted to the main body 210 and arranged to roll with respect to the main body for allowing the main body 210 to be rolled along a surface. The support assembly 220 houses a component of the appliance, such as a motor for driving a surface-agitating device. Alternatively, or additionally, the support assembly may accommodate a fluid inlet 531 for receiving fluid flow, a fluid outlet 535 for exhausting fluid and a fluid filter.
Patent NZ-541151-A (NZ)
Title: Triazolopyridazines as protein kinase inhibitors
Inventor: GREEN JEREMY
IPC: A61K31/503
Filed: 2003-12-17
Abstract: Disclosed are triazolopyridazines of formula (I) wherein R1 is NR3R4 and the remaining substituents are as described in the specification. Compounds of the type disclosed are inhibitors of PIM-1, CDK-2, SRC and GSK-3 protein kinases and are useful in the treatment of proliferative, cardiac, neurodegenerative, autoimmune, inflammatory, immunologically mediated, viral and bone disorders.
Patent NZ-545425-A (NZ)
Title: A drive system
Inventor: JENNINGS ROBERT NOEL
IPC: B31B50/52
Filed: 2006-02-17
Abstract: A drive system for the forming ram of packing machinery includes a rotary drive 2, a linear drive 3 configured to drive the forming ram and a converter which converts the output from the rotary drive 2 to the input of the linear drive 3. In the extended position, the forming ram extends substantially beyond one end of the linear drive.
Patent NZ-550271-A (NZ)
Title: Trestle-type work platform
Inventor: DHARMARAJ ELVIN
IPC: B25H1/06
Filed: 2006-10-03
Abstract: A work platform including: a work support member (22); at least two support frames (23), each support frame having at least two elongate leg members (25) for supporting the work support member in a working position; at least two connector members (31), each connector member having depending formations which mount the at least two elongate leg members of the support frame by means of complementary formations provided by the leg members; and one or more brackets (33) attachable to the work support member by one or more fasteners. Each connector member is hingedly mounted to a corresponding bracket such that each support frame is rotatable between the working position and a folded position.
Patent NZ-554933-A (NZ)
Title: Competitive binding assay for identifying inhibitors of HCV polymerase
Inventor: KUKOLJ GEORGE
IPC: G01N33/542
Filed: 2002-08-05
Abstract: Disclosed is a method for identifying compounds binding to HCV polymerase comprising the steps of: a) contacting said HCV polymerase or an analog thereof with a probe being capable of binding to an HCV polymerase or an analog thereof, said probe being displaceable by an inhibitor thereof, so as to form a complex comprising said probe bound to said polymerase; b) measuring a signal emitted from said probe in said complex to establish a baseline level; c) incubating the product of step a) with a test compound; and d) measuring the signal from said complex; and e) comparing the signal from step d) with the signal from step b); whereby a modulation in said signal is an indication that said test compound binds to said polymerase. The probe comprises a detectable label attached to any suitable position.
Patent NZ-563324-A (NZ)
Title: Ball suitable for water games with a gel interior and a flotation enhancing layer
Inventor: HELAND JON VON
IPC: A63B37/02
Filed: 2005-05-20
Abstract: A ball (10) suitable for water games is disclosed. The ball (10) has a gel core (26) surrounded a floating enhancement section (28). The floating enhancement section (28) in turn is covered by an outer elastic shell (20). The floating enhancement section (26) in the interior of the ball is made from a plastic material and gas. Such a material may be a foamed polyurethane. The diameter of the gel core (26) is thicker than the thickness of the floating enhancement section (28).
Patent NZ-565041-A (NZ)
Title: Aryl substituted pyridinediyl and thiazolediyl amides comprising a saturated linker group
Inventor: STROBEL HARTMUT
IPC: A61K31/425
Filed: 2006-06-14
Abstract: Disclosed are aryl substituted pyridinediyl and thiazolediyl amides which comprise a saturated linker group and are represented by the general formula (I), wherein, A is chosen from -CH2-CH2-CH2- and -Y-CH2-CH2-, wherein all CH2 groups can be substituted by one or more identical or different substituents R4, and wherein Y is chosen from O, S and NR11 and Y is bonded to the group Het; Het is a pyridinediyl or thiazolediyl group which can all be substituted by one or more identical or different substituents R5; X is a direct bond; R1 and R2, together with the N-CO group which carries them, form a 4-membered to 10-membered, monocyclic or bicyclic, saturated or unsaturated ring; and where the other substituents are as defined herein. Also disclosed is a composition containing a compound as defined above for use in the treatment of cardiovascular diseases, angina pectoris, coronary heart disease etc.
Patent NZ-566009-A (NZ)
Title: Intermediate compound for synthesizing pharmaceutical agent and production method thereof
Inventor: OKUYAMA MASAHIRO
IPC: C07D265/30
Filed: 2006-07-21
Abstract: Disclosed is a method for synthesizing an optically active 2-(2-arylmorpholin-4-yl)-1-methyl-1H-[4,4']bipyrimidinyl-6-one represented by the formula (I) wherein R is an aryl or a heteroaryl) and a carbon atom marked with * is an asymmetric carbon atom; which comprises Step (1) or Step (2): Step (1) synthesizing an optically active compound represented by the amine 5: wherein R is an aryl or a heteroaryl, X1 is a halogen, and R1 is an alkyl, an aralkyl or an alkenyl; reacting a compound of the formula 1 with a borane or complex thereof in a solvent in the presence of (S)-2-methyl-CBS-oxazaborolidine to give a alcohol 2, reacting the alcohol of the formula 2 with a base in a solvent to give a epoxide of the formula 3, and reacting the epoxide of the formula 3 with an amine of the formula 4 to give the aminoalcohol of the formula 5. Step (2) synthesizing an optically active amino alcohol represented by the formula 25, wherein R is an aryl or a heteroaryl, X1 is a halogen, and R1 is an alkyl, an aralkyl or an alkenyl, reacting a ketone of the formula 21 with a borane or complex thereof in a solvent in the presence of (R)-2-methyl-CBS-oxazaborolidine to give a alcohol of the formula 22, reacting the alcohol of the formula 22 with a base in a solvent to give a epoxide of the formula 23, and reacting the epoxide of the formula 23 with an amine of the formula 24 to give a amino alcohol of the formula 25.